Journal profile · Medicine-General Medicine
Biomedical Journal
ISSN 2319-4170 · eISSN 2320-2890 · Wolters Kluwer Medknow Publications · Netherlands
Biomedical Journal: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.99; fully open access; APC about USD 2,700; median 118 days to acceptance (99 articles, last 24 months); 79 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Biomedical Journal is published by Wolters Kluwer Medknow Publications and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Educational Robotics and Engineering, Diverse Scientific and Economic Studies and Human auditory perception and evaluation, together about 23.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Peer review under responsibility of Chang Gung UniversityBiomedical Journal publishes 6 peer-reviewed issues per year in all fields of clinical and biomedical sciences for an internationally diverse readership for authors from around the world.Clinical studies, accounts of clinical trials, biomarker studies, and characterization of human pathogens are within the scope of the journal, as well as basic studies in model species such as Escherichia coli, Caenorhabditis elegans, Drosophila melanogaster, and Mus musculus revealing the function of molecules, the function of cells, and the characteristics of tissues relevant for human health. However, articles on other species can be published if they contribute to our understanding of basic mechanisms of biology.A highly-cited international editorial board assures timely publication of manuscripts. Reviews on recent progress in biomedical sciences are commissioned by the editors.
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editor-in-chief Ming-Ling KuoPublisher website
Editorial board by country: 2 in mainland China (about 3%); most named Taiwan, China 49, United States 7, France 5, Mainland China 2, Israel 2 (66 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Educational Robotics and EngineeringComputer Science8%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance7.8%
- Human auditory perception and evaluationEngineering7.8%
- COVID-19 Clinical Research StudiesMedicine6.7%
- Immune Cell Function and InteractionImmunology and Microbiology6.7%
- SARS-CoV-2 and COVID-19 ResearchMedicine6.2%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology3.9%
- T-cell and B-cell ImmunologyImmunology and Microbiology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.99LetPub ·
- Impact factor (publisher)
- 6.3Publisher website ·
- CiteScore 2026-06
- 11.6LetPub ·
- CiteScore (publisher)
- 11.6Publisher website ·
- SJR 2026-06
- 1.36LetPub ·
- SNIP 2026-06
- 1.61LetPub ·
- h-index
- 23LetPub ·
- h-index
- 71OpenAlex ·
- i10-index
- 627OpenAlex ·
- 2-year mean citedness
- 4.81OpenAlex ·
- Self-citation rate
- 6.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 63LetPub ·
Articles by year OpenAlex count · 1,172 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 72 | 72 | 52 |
| 2025 | 79 | 79 | 364 |
| 2024 | 86 | 86 | 724 |
| 2023 | 85 | 85 | 1,548 |
| 2022 | 84 | 84 | 1,149 |
| 2021 | 132 | 132 | 2,841 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
118 daysMedian, submission to acceptance · P25–P75 82 days – 168 days
- Acceptance to online
- median 1 days (99 articles)
- Submission to online
- median 120 days
- Sample
- 99 articles with submission and acceptance dates (204 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 40 weeksLetPub ·
- Submission to first decision
- 15 daysPublisher website ·
- First decision after review
- 74 daysPublisher website ·
- Submission to acceptance
- 129 daysPublisher website ·
- Acceptance to publication
- 4 daysPublisher website ·
- Submission to publication (journal-reported)
- about 59 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,700 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,700 / EUR 2,530 / GBP 2,160 / JPY 334,880 | — | — | |
| LetPub | USD 2,700 | Yes | — | |
| Publisher website | USD 1,498.5 / USD 2,700 | — | — |
Other charges and waivers (author guidelines)
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 5,000 words
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX and Word
Article types accepted7
- brief communicationContributions falling into the following categories will be considered for publication: Original Article, Review Article (commissioned), News and Perspectives (…Length not stated
- correspondenceContributions falling into the following categories will be considered for publication: Original Article, Review Article (commissioned), News and Perspectives (…Length not stated
- editorialContributions falling into the following categories will be considered for publication: Original Article, Review Article (commissioned), News and Perspectives (…Length not stated
- letter to editorContributions falling into the following categories will be considered for publication: Original Article, Review Article (commissioned), News and Perspectives (…Length not stated
- news and perspectivesContributions falling into the following categories will be considered for publication: Original Article, Review Article (commissioned), News and Perspectives (…Length not stated
- original articleContributions falling into the following categories will be considered for publication: Original Article, Review Article (commissioned), News and Perspectives (…Length not stated
- review articleContributions falling into the following categories will be considered for publication: Original Article, Review Article (commissioned), News and Perspectives (…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
generative AI use must be declared Model summary
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, …
Source ↗Publisher website ·- Conflicts of interest
declaration of interests required Model summary
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work.
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Medknow Publications
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2319-4170
- Electronic ISSN
- 2320-2890
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Biomedical Journal
What CAS zone is Biomedical Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biomedical Journal is in Zone 3 of Medicine, and in Zone 3 of the minor category Biochemistry & Molecular Biology / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biomedical Journal?
The latest impact factor listed by LetPub is 5.99; CiteScore 11.6, h-index 71.
How long does peer review take at Biomedical Journal?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 118 days (interquartile range 82–168 days); authors report an average review time of about 40 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Biomedical Journal?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Manuscript length: ≤ 5,000 words; Reference style: Numbered, in order of citation; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Biomedical Journal based?
Of the 66 board members whose country the journal's board page names, 2 (about 3%) are in mainland China; the countries named most often are Taiwan, China (49), United States (7) and France (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Biomedical Journal?
According to LetPub and DOAJ records, Biomedical Journal is indexed in SCIE, Scopus and DOAJ.
Is Biomedical Journal open access, and what is the APC?
Biomedical Journal is a fully open-access journal. APC about USD 2,700.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .